FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000699183> ?p ?o ?g. }

• W2000699183 endingPage "796" @default.
• W2000699183 startingPage "787" @default.
• W2000699183 abstract "Objective:To conduct a network meta-analysis (NMA) to assess the relative efficacy and safety of simeprevir, a second generation oral protease inhibitor (PI), compared to telaprevir and boceprevir in combination with pegylated interferon-α and ribavirin (PR) in patients with chronic hepatitis C.Methods:A systematic literature review and NMA of randomized controlled trials involving anti-virals added to PR were conducted. Electronic database searches and hand searches were conducted to identify relevant publications. Outcomes of interest included sustained virologic response (SVR), incidence of adverse events (AEs), and discontinuation due to AEs. Networks were based on treatment-, dose-, and duration-specific nodes. Sub-group analyses were conducted to investigate heterogeneity, based on Metavir scores, sub-genotypes 1a/1b, and prior response.Results:A total of 15 publications were considered for the base case of the meta-analysis. Simeprevir was associated with higher SVR rates than PR alone. Compared to telaprevir and boceprevir, SVR rates tended to be higher for simeprevir, with odds ratios ranging from 1.27 [0.81–2.00] to 2.61 [1.44–4.74] in treatment-naïve and from 1.04 [0.78–1.38] to 1.74 [0.84–3.61] in treatment-experienced patients, respectively. In terms of safety, the risks of anemia and discontinuations due to AEs were lower for simeprevir compared to PR alone, telaprevir, and boceprevir. The risk of rash was lower for simeprevir compared to telaprevir, and similar compared to PR alone and boceprevir.Conclusion:This NMA in genotype 1 HCV patients suggests a similar or better efficacy and tolerability profile for simeprevir compared to telaprevir and boceprevir." @default.
• W2000699183 created "2016-06-24" @default.
• W2000699183 creator A5002152360 @default.
• W2000699183 creator A5008958385 @default.
• W2000699183 creator A5021847624 @default.
• W2000699183 creator A5022627540 @default.
• W2000699183 creator A5029354925 @default.
• W2000699183 creator A5031916706 @default.
• W2000699183 creator A5063754167 @default.
• W2000699183 creator A5067010995 @default.
• W2000699183 date "2015-05-26" @default.
• W2000699183 modified "2023-09-27" @default.
• W2000699183 title "A network meta-analysis to compare simeprevir with boceprevir and telaprevir in combination with peginterferon-<i>α</i>and ribavirin in patients infected with genotype 1 Hepatitis C virus" @default.
• W2000699183 cites W1504183466 @default.
• W2000699183 cites W1505367831 @default.
• W2000699183 cites W1945909195 @default.
• W2000699183 cites W1972930488 @default.
• W2000699183 cites W1979174109 @default.
• W2000699183 cites W1983765304 @default.
• W2000699183 cites W1992909913 @default.
• W2000699183 cites W2004876716 @default.
• W2000699183 cites W2010699829 @default.
• W2000699183 cites W2016278419 @default.
• W2000699183 cites W2026329262 @default.
• W2000699183 cites W2027545702 @default.
• W2000699183 cites W2035613798 @default.
• W2000699183 cites W2044786295 @default.
• W2000699183 cites W2046309921 @default.
• W2000699183 cites W2046658390 @default.
• W2000699183 cites W2052005188 @default.
• W2000699183 cites W2057765075 @default.
• W2000699183 cites W2064546869 @default.
• W2000699183 cites W2075282196 @default.
• W2000699183 cites W2094972821 @default.
• W2000699183 cites W2100797437 @default.
• W2000699183 cites W2104823579 @default.
• W2000699183 cites W2112876622 @default.
• W2000699183 cites W2119764771 @default.
• W2000699183 cites W2122265483 @default.
• W2000699183 cites W2122987848 @default.
• W2000699183 cites W2124666341 @default.
• W2000699183 cites W2125776201 @default.
• W2000699183 cites W2125963799 @default.
• W2000699183 cites W2127189337 @default.
• W2000699183 cites W2127685726 @default.
• W2000699183 cites W2132290252 @default.
• W2000699183 cites W2132309970 @default.
• W2000699183 cites W2134790296 @default.
• W2000699183 cites W2138363476 @default.
• W2000699183 cites W2141214317 @default.
• W2000699183 cites W2143244227 @default.
• W2000699183 cites W2143559032 @default.
• W2000699183 cites W2153429965 @default.
• W2000699183 cites W2159055202 @default.
• W2000699183 cites W2171280425 @default.
• W2000699183 doi "https://doi.org/10.3111/13696998.2015.1046880" @default.
• W2000699183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25934147" @default.
• W2000699183 hasPublicationYear "2015" @default.
• W2000699183 type Work @default.
• W2000699183 sameAs 2000699183 @default.
• W2000699183 citedByCount "6" @default.
• W2000699183 countsByYear W20006991832015 @default.
• W2000699183 countsByYear W20006991832016 @default.
• W2000699183 countsByYear W20006991832017 @default.
• W2000699183 countsByYear W20006991832019 @default.
• W2000699183 countsByYear W20006991832022 @default.
• W2000699183 crossrefType "journal-article" @default.
• W2000699183 hasAuthorship W2000699183A5002152360 @default.
• W2000699183 hasAuthorship W2000699183A5008958385 @default.
• W2000699183 hasAuthorship W2000699183A5021847624 @default.
• W2000699183 hasAuthorship W2000699183A5022627540 @default.
• W2000699183 hasAuthorship W2000699183A5029354925 @default.
• W2000699183 hasAuthorship W2000699183A5031916706 @default.
• W2000699183 hasAuthorship W2000699183A5063754167 @default.
• W2000699183 hasAuthorship W2000699183A5067010995 @default.
• W2000699183 hasBestOaLocation W20006991831 @default.
• W2000699183 hasConcept C126322002 @default.
• W2000699183 hasConcept C159047783 @default.
• W2000699183 hasConcept C197934379 @default.
• W2000699183 hasConcept C2522874641 @default.
• W2000699183 hasConcept C2776408679 @default.
• W2000699183 hasConcept C2776461080 @default.
• W2000699183 hasConcept C2777159539 @default.
• W2000699183 hasConcept C2778159067 @default.
• W2000699183 hasConcept C2778986448 @default.
• W2000699183 hasConcept C2780040827 @default.
• W2000699183 hasConcept C71924100 @default.
• W2000699183 hasConcept C90924648 @default.
• W2000699183 hasConceptScore W2000699183C126322002 @default.
• W2000699183 hasConceptScore W2000699183C159047783 @default.
• W2000699183 hasConceptScore W2000699183C197934379 @default.
• W2000699183 hasConceptScore W2000699183C2522874641 @default.
• W2000699183 hasConceptScore W2000699183C2776408679 @default.
• W2000699183 hasConceptScore W2000699183C2776461080 @default.
• W2000699183 hasConceptScore W2000699183C2777159539 @default.
• W2000699183 hasConceptScore W2000699183C2778159067 @default.
• W2000699183 hasConceptScore W2000699183C2778986448 @default.
• W2000699183 hasConceptScore W2000699183C2780040827 @default.

• next